The Strategic Research Programme in Cancer (StratCan)
The Strategic Research Programme in Cancer (StratCan) combines cancer biology with clinical oncology by bringing together top level cancer scientists from different disciplines. The overall goal is to generate new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society. The programme is supported by the government through the strategic initiatives.
Cancer is one of the world's most common diseases and a major cause of death. In Sweden it is expected that cancer incidence will continue to rise and that cancer prevalence will double by 2030. New research strategies aiming at effective prevention and improved treatment are therefore urgently needed.
The programme, aiming to advance cancer research to the highest level, will build on and expand the existing strength in research on cancer biology at Karolinska Institutet. Specific initiatives will be introduced to enhance translation of basic research into improved means of cancer preventions, diagnosis and therapy.
Understanding cancer biology is a prerequisite for the future success of cancer treatment and the proposed research themes fall within four interconnected areas that bridge basic science and clinical oncology.
- Prevention and early detection
- Functional annotation of genomic data
- Tumor microenvironment
- Targeted therapy and personalized treatment